Selected Grants
A Phase 2, adaptive, double-blinded, placebo-controlled, randomized, multi-center trial to evaluate the efficacy, safety and tolerability of intracoronary infusion of AB-1002 in adult subjects with New York Heart Association (NYHA) Class III
Clinical TrialPrincipal Investigator · Awarded by AskBio · 2025 - 2030A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
Clinical TrialCo Investigator · Awarded by Kardigan Inc. · 2026 - 2030Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants with Heart Failure with Preserved Ejection Fraction and Left Ventricular Hypertrophy
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2026 - 2029External Relationships
- ASK-BIO/ACTUS
- Campbell University Schol of Osteopathic Medicine
- Novo Nordisk
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.